As therapy inefficacy and subsequent metastases drive breast cancer mortality, further elucidation of both intracellular and extracellular AGR2 biology and its ability to confer hormone therapy resistance may lead to improved understanding of breast cancer mortality. The gene discussed is AGR2; the disease is breast carcinoma.